# A Study of a Candidate COVID-19 Vaccine (COV003)

> **NCT04536051** · PHASE3 · UNKNOWN · sponsor: **University of Oxford** · enrollment: 10300 (estimated)

## Conditions studied

- Coronavirus

## Interventions

- **BIOLOGICAL:** ChAdOx1 nCoV-19 single dose + paracetamol
- **BIOLOGICAL:** MenACWY single dose + paracetamol
- **BIOLOGICAL:** ChAdOx1 nCoV-19 two dose + paracetamol
- **BIOLOGICAL:** MenACWY prime & saline placebo boost + paracetamol

## Key facts

- **NCT ID:** NCT04536051
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-02
- **Primary completion:** 2021-09
- **Final completion:** 2021-09
- **Target enrollment:** 10300 (ESTIMATED)
- **Last updated:** 2020-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04536051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04536051, "A Study of a Candidate COVID-19 Vaccine (COV003)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04536051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*